Atria Wealth Solutions Inc. acquired a new position in shares of Tempus AI, Inc. (NASDAQ:TEM – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,515 shares of the company’s stock, valued at approximately $214,000.
Several other institutional investors and hedge funds have also bought and sold shares of TEM. Vanguard Group Inc. lifted its position in Tempus AI by 6,247.5% during the first quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after purchasing an additional 5,900,668 shares during the period. ARK Investment Management LLC lifted its position in Tempus AI by 35.9% during the first quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock worth $361,867,000 after purchasing an additional 1,981,755 shares during the period. Nikko Asset Management Americas Inc. lifted its position in Tempus AI by 31.5% during the first quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock worth $205,401,000 after purchasing an additional 1,021,460 shares during the period. Sumitomo Mitsui Trust Group Inc. raised its stake in Tempus AI by 31.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock worth $205,284,000 after acquiring an additional 1,016,384 shares in the last quarter. Finally, CloudAlpha Capital Management Limited Hong Kong acquired a new position in Tempus AI during the first quarter worth about $34,119,000. Institutional investors own 24.22% of the company’s stock.
Insider Buying and Selling
In related news, CEO Eric P. Lefkofsky sold 332,500 shares of the stock in a transaction on Thursday, September 25th. The stock was sold at an average price of $76.56, for a total value of $25,456,200.00. Following the completion of the sale, the chief executive officer directly owned 9,141,032 shares of the company’s stock, valued at approximately $699,837,409.92. This represents a 3.51% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Ryan Fukushima sold 17,460 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $1,303,389.00. Following the completion of the sale, the chief operating officer directly owned 839,180 shares of the company’s stock, valued at $62,644,787. The trade was a 2.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 933,662 shares of company stock worth $68,070,993 over the last quarter. Corporate insiders own 26.27% of the company’s stock.
Wall Street Analysts Forecast Growth
Read Our Latest Report on Tempus AI
Tempus AI Stock Performance
NASDAQ:TEM opened at $85.27 on Thursday. The company has a market capitalization of $14.81 billion, a PE ratio of -71.66 and a beta of 4.87. The company has a 50 day simple moving average of $83.58 and a two-hundred day simple moving average of $67.01. The company has a debt-to-equity ratio of 2.58, a quick ratio of 1.43 and a current ratio of 1.54. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $104.32.
Tempus AI (NASDAQ:TEM – Get Free Report) last posted its quarterly earnings results on Friday, August 8th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. The firm had revenue of $314.64 million for the quarter, compared to analysts’ expectations of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company’s revenue for the quarter was up 89.5% compared to the same quarter last year. During the same period in the prior year, the business earned ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. Research analysts anticipate that Tempus AI, Inc. will post -6.15 earnings per share for the current year.
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Further Reading
- Five stocks we like better than Tempus AI
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- Archer’s Recent String of Victories Signals a New Phase of Growth
- Stock Dividend Cuts Happen Are You Ready?
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- What is Short Interest? How to Use It
- The Best AI for Picking Stocks, Ranked by Performance
Want to see what other hedge funds are holding TEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tempus AI, Inc. (NASDAQ:TEM – Free Report).
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.